BIO Asia–Taiwan 2023 亞洲生技大會

Values Beyond Boundaries

With two months until the launch of BIO Asia–Taiwan 2022, major industry players have confirmed their participation, with talks scheduled from representatives of IQVIA, Merck, imec, Roche, Syneos Health, Novartis, Medidata, Eirgenix, KPMG, Amarex, and Johnson & Johnson and others. And don't miss the always popular investment exit Strategies session, hosted again this year by PriceWaterhouseCoopers (PwC). Register now to confirm your place and begin making preparations to participate onsite or online at Asia's premier biomedical gathering; BIO Asia–Taiwan 2022. Join us and make the most of this exciting opportunity to link into the Asian biotech value chain!

2022 Program on July 25-31 in Taipei

EARLY BIRD registration is On or before Jun. 20
for the BIO Asia–Taiwan 2022 Conference!